Arteriosclerosis, Vol 9, 335-344, Copyright © 1989 by American Heart Association

ARTICLES

Apolipoprotein, low density lipoprotein subfraction, and insulin associations with familial combined hyperlipidemia. Study of Utah patients with familial dyslipidemic hypertension

SC Hunt, LL Wu, PN Hopkins, BM Stults, H Kuida, ME Ramirez, JM Lalouel and RR Williams
Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City.

Familial dyslipidemic hypertension (FDH) is a syndrome recently described from sibships selected for early familial hypertension and found to have one or more of three fasting lipid abnormalities [high triglycerides, low high density lipoprotein (HDL) cholesterol, high low density lipoprotein (LDL) cholesterol]. In further analyses of these same 131 hypertensive subjects, apolipoprotein A-I and B, fasting plasma insulin (adjusted for body mass index), and detailed anthropometrics were different in two subgroups of FDH. Of 63 FDH patients, 19 met the criteria for familial combined hyperlipidemia (FCHL); 44 did not, but still had high triglyceride and/or low HDL cholesterol levels. When compared to 20 normolipidemic hypertensive patients, the 19 hypertensive patients with FCHL had 196% higher very low density lipoprotein cholesterol (p = 0.0001), 33% higher apolipoprotein B (p = 0.0002), smaller LDL particles (p = 0.007), and 73% higher fasting insulin (p = 0.003), but no significant differences in body mass index or skinfold thicknesses. The other 44 FDH patients without FCHL had 33% lower HDL (p = 0.0001), with only 8% lower apolipoprotein A-I levels (p = 0.20); significantly higher subscapular skinfolds (p = 0.02), weights (p = 0.002), body mass index (p = 0.006), knee widths (p = 0.0007), and wrist circumferences (p = 0.0009); smaller, denser LDL subfractions (p = 0.001); and increased apolipoprotein B levels (p = 0.01) compared to the normolipidemic hypertensive group. Increased fasting insulin levels were similar to the normolipidemic group and significantly lower than the FCHL group after adjustment for body mass index, suggesting a relationship between obesity and fasting insulin levels only in the non-FCHL group. We conclude that FDH consists of at least two subgroups: 1) FCHL with high apolipoprotein B, small LDL particles, and increased fasting plasma insulin levels, and 2) a less well-defined residual having upper central obesity with low HDL cholesterol and high triglyceride levels. Elevated insulin levels found in both groups, but possibly originating through different physiological mechanisms, may provide the pathophysiological connections between dyslipidemia, obesity, and hypertension.

This article has been cited by other articles:

				M. Adiels, S.-O. Olofsson, M.-R. Taskinen, and J. Boren Overproduction of Very Low-Density Lipoproteins Is the Hallmark of the Dyslipidemia in the Metabolic Syndrome Arterioscler Thromb Vasc Biol, July 1, 2008; 28(7): 1225 - 1236. [Abstract] [Full Text] [PDF]

				E. S. van Aalst-Cohen, A. C.M. Jansen, M. W.T. Tanck, J. C. Defesche, M. D. Trip, P. J. Lansberg, A. F.H. Stalenhoef, and J. J.P. Kastelein Diagnosing familial hypercholesterolaemia: the relevance of genetic testing Eur. Heart J., September 2, 2006; 27(18): 2240 - 2246. [Abstract] [Full Text] [PDF]

				H. D. Sesso, J. E. Buring, M. J. Chown, P. M Ridker, and J. M. Gaziano A Prospective Study of Plasma Lipid Levels and Hypertension in Women Arch Intern Med, November 14, 2005; 165(20): 2420 - 2427. [Abstract] [Full Text] [PDF]

				A. Soro, M. Jauhiainen, C. Ehnholm, and M.-R. Taskinen Determinants of low HDL levels in familial combined hyperlipidemia J. Lipid Res., August 1, 2003; 44(8): 1536 - 1544. [Abstract] [Full Text] [PDF]

				M.J. Landray, E. Edmunds, F.L. Li-saw-hee, B.A. Hughes, D.G. Beevers, M.J. Kendall, and G.Y.H. Lip Abnormal low-density lipoprotein subfraction profile in patients with untreated hypertension QJM, March 1, 2002; 95(3): 165 - 171. [Abstract] [Full Text] [PDF]

				M. J. Veerkamp, J. de Graaf, S. J.H. Bredie, J. C.M. Hendriks, P. N.M. Demacker, and A. F.H. Stalenhoef Diagnosis of Familial Combined Hyperlipidemia Based on Lipid Phenotype Expression in 32 Families: Results of a 5-Year Follow-Up Study Arterioscler Thromb Vasc Biol, February 1, 2002; 22(2): 274 - 282. [Abstract] [Full Text] [PDF]

				S.C. Elbein and S.J. Hasstedt Quantitative Trait Linkage Analysis of Lipid-Related Traits in Familial Type 2 Diabetes: Evidence for Linkage of Triglyceride Levels to Chromosome 19q Diabetes, February 1, 2002; 51(2): 528 - 535. [Abstract] [Full Text] [PDF]

				J. Pihlajamaki, M. Austin, K. Edwards, and M. Laakso A Major Gene Effect on Fasting Insulin and Insulin Sensitivity in Familial Combined Hyperlipidemia Diabetes, October 1, 2001; 50(10): 2396 - 2401. [Abstract] [Full Text]

				H. Allayee, T. W.A. de Bruin, K. Michelle Dominguez, L. S.-C. Cheng, E. Ipp, R. M. Cantor, K. L. Krass, E. T.P. Keulen, B. E. Aouizerat, A. J. Lusis, et al. Genome Scan for Blood Pressure in Dutch Dyslipidemic Families Reveals Linkage to a Locus on Chromosome 4p Hypertension, October 1, 2001; 38(4): 773 - 778. [Abstract] [Full Text] [PDF]

				A. D. Sniderman, T. Scantlebury, and K. Cianflone Hypertriglyceridemic HyperapoB: The Unappreciated Atherogenic Dyslipoproteinemia in Type 2 Diabetes Mellitus Ann Intern Med, September 18, 2001; 135(6): 447 - 459. [Abstract] [Full Text] [PDF]

				J. Q. Purnell, S. E. Kahn, R. S. Schwartz, and J. D. Brunzell Relationship of Insulin Sensitivity and ApoB Levels to Intra-abdominal Fat in Subjects With Familial Combined Hyperlipidemia Arterioscler Thromb Vasc Biol, April 1, 2001; 21(4): 567 - 572. [Abstract] [Full Text] [PDF]

				J. Ribalta, J. Girona, J. C. Vallvé, A. E. La Ville, M. Heras, and L. Masana Vitamin A is linked to the expression of the AI-CIII-AIV gene cluster in familial combined hyperlipidemia J. Lipid Res., March 1, 1999; 40(3): 426 - 431. [Abstract] [Full Text]

				L. Karjalainen, J. Pihlajamaki, P. Karhapaa, and M. Laakso Impaired Insulin-Stimulated Glucose Oxidation and Free Fatty Acid Suppression in Patients with Familial Combined Hyperlipidemia : A Precursor Defect for Dyslipidemia? Arterioscler Thromb Vasc Biol, October 1, 1998; 18(10): 1548 - 1553. [Abstract] [Full Text] [PDF]

				A. D. Sniderman, K. Cianflone, P. Arner, L. K. M. Summers, and K. N. Frayn The Adipocyte, Fatty Acid Trapping, and Atherogenesis Arterioscler Thromb Vasc Biol, February 1, 1998; 18(2): 147 - 151. [Full Text] [PDF]

				D. L. Rainwater, B. D. Mitchell, M. C. Mahaney, and S. M. Haffner Genetic Relationship Between Measures of HDL Phenotypes and Insulin Concentrations Arterioscler Thromb Vasc Biol, December 1, 1997; 17(12): 3414 - 3419. [Abstract] [Full Text]

				S.-H. H. Juo, T. H. Beaty, and P. O. Kwiterovich Jr Etiologic Heterogeneity of Hyperapobetalipoproteinemia (HyperapoB) : Results From Segregation Analysis in Families With Premature Coronary Artery Disease Arterioscler Thromb Vasc Biol, November 1, 1997; 17(11): 2729 - 2736. [Abstract] [Full Text]

				S. Reynisdottir, B. Angelin, D. Langin, H. Lithell, M. Eriksson, C. Holm, and P. Arner Adipose Tissue Lipoprotein Lipase and Hormone-Sensitive Lipase : Contrasting Findings in Familial Combined Hyperlipidemia and Insulin Resistance Syndrome Arterioscler Thromb Vasc Biol, October 1, 1997; 17(10): 2287 - 2292. [Abstract] [Full Text]

				J. Pihlajamaki, J. Rissanen, S. Heikkinen, L. Karjalainen, and M. Laakso Codon 54 Polymorphism of the Human Intestinal Fatty Acid Binding Protein 2 Gene Is Associated With Dyslipidemias But Not With Insulin Resistance in Patients With Familial Combined Hyperlipidemia Arterioscler Thromb Vasc Biol, June 1, 1997; 17(6): 1039 - 1044. [Abstract] [Full Text]

				S.J.H. Bredie, J. van Drongelen, L.A. Kiemeney, P.N.M. Demacker, T.H. Beaty, and A.F.H. Stalenhoef Segregation Analysis of Plasma Apolipoprotein B Levels in Familial Combined Hyperlipidemia Arterioscler Thromb Vasc Biol, May 1, 1997; 17(5): 834 - 840. [Abstract] [Full Text]

				T. J. Aitman, I. F. Godsland, B. Farren, D. Crook, H. J. Wong, and J. Scott Defects of Insulin Action on Fatty Acid and Carbohydrate Metabolism in Familial Combined Hyperlipidemia Arterioscler Thromb Vasc Biol, April 1, 1997; 17(4): 748 - 754. [Abstract] [Full Text]

				S. M. Haffner, H. Miettinen, S. P. Gaskill, and M. P. Stern Metabolic Precursors of Hypertension: The San Antonio Heart Study Arch Intern Med, September 23, 1996; 156(17): 1994 - 2001. [Abstract] [PDF]

				R. A. Hegele, J. H. Brunt, and P. W. Connelly Genetic and Biochemical Factors Associated With Variation in Blood Pressure in a Genetic Isolate Hypertension, February 1, 1996; 27(2): 308 - 312. [Abstract] [Full Text]

				A. H. Slyper Low-Density Lipoprotein Density and Atherosclerosis: Unraveling the Connection JAMA, July 27, 1994; 272(4): 305 - 308. [Abstract] [PDF]

				W. A. Wattigney, D. W. Harsha, S. R. Srinivasan, L. S. Webber, and G. S. Berenson Increasing Impact of Obesity on Serum Lipids and Lipoproteins in Young Adults: The Bogalusa Heart Study Arch Intern Med, October 1, 1991; 151(10): 2017 - 2022. [Abstract] [PDF]

				S. M. Haffner, M. P. Stern, H. P. Hazuda, B. D. Mitchell, and J. K. Patterson Cardiovascular Risk Factors in Confirmed Prediabetic Individuals: Does the Clock for Coronary Heart Disease Start Ticking Before the Onset of Clinical Diabetes? JAMA, June 6, 1990; 263(21): 2893 - 2898. [Abstract] [PDF]

				R. R. Williams, P. N. Hopkins, S. C. Hunt, L. L. Wu, S. J. Hasstedt, J. M. Lalouel, K. O. Ash, B. M. Stults, and H. Kuida Population-Based Frequency of Dyslipidemia Syndromes in Coronary-Prone Families in Utah Arch Intern Med, March 1, 1990; 150(3): 582 - 588. [Abstract] [PDF]